This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Key Topics in the Diagnosis and Treatment of HF - A Webinar Series

Key Topics in the Diagnosis and Treatment of HF - A Webinar Series

Format

Webcast

Time to Complete

2 hours
(4 Webinar Chapters)

Released

November 15, 2017

Expires

November 15, 2018
Add to Queue


Maximum Credits

2.00 / AMA PRA Category 1 CreditsTM
2.00 / CNE for Nurses (0.80 pharmacotherapy hours)

Accredited Provider

This activity is jointly provided by Global Education Group and the Cardiometabolic Health Congress.

Commercial Supporter

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Program Description

Over the course of four 30-minute webinars, experts will address knowledge and competency gaps regarding heart failure (HF) management and treatment. The series of topics include:

I. Assessment and Diagnosis of Patients at Risk for HF
II. Treatment of HFrEF in the Cardiometabolic Patient
III. Management of HF in Special Populations
IV. Coordination of Care: HF Patient Follow-up

Patient cases will be presented to demonstrate the utilization of recommended guidelines for the management and treatment of HF, and the individualization of HF treatment in complex patients, including those patients who are African American and have CKD.

Intended Audience

The educational design of this activity addresses the needs of US-based healthcare professionals, including: physicians (MDs), nurse practitioners (NPs), physician assistants (PAs), nurses, and other allied health professionals.

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Identify patients who would benefit from hypertensive treatment based on risk profile, underlying comorbidities, and recommended guidelines and evidence-based clinical trials
  • Explain how to develop hypertensive treatment regimens based on recommended treatment guidelines and the benefits and risks of currently available pharmacotherapies
  • Discuss treatment in patients with HF based on recommended guidelines, patient-risk profiles, comorbidities, and the benefits and risks of currently available pharmacotherapies
  • Describe when it is necessary to call for a cardiology consult or refer a patient to a cardiologist to optimize patient outcomes

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty

Alanna Morris, MD
Assistant Professor of Medicine
Division of Cardiology
Emory University Clinical Cardiovascular
Research Institute
Atlanta, GA

Dr. Morris discloses the following:
Consultant/Independent Contractor: Novartis

Keith C. Ferdinand, MD
Professor of Medicine
Tulane University School of Medicine
Tulane Heart and Vascular Institute
New Orleans, LA

Dr. Ferdinand discloses the following:
Consultant/Independent Contractor: Quantum Genomics, Novartis, Amgen, Sanofi, Eli Lilly
Grant/Research Support: Boehringer Ingelheim

Accredited Provider Disclosure

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN, has nothing to disclose.
Andrea Funk has nothing to disclose.
Liddy Knight has nothing to disclose.
Jeanelle Spencer, PhD, has nothing to disclose.
Erin Franceschini, MS, has nothing to disclose.
Karin McAdams has nothing to disclose.

Credit

2.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this live activity for a maximum of 2.00 AMA PRA Category 1 CreditsTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

2.00

Type

CNE Contact Hour(s)

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

This educational activity for 2.00 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes 0.80 pharmacotherapy hours.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this activity, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.

If you have any other questions relating to your certificate or other issues with the activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue